Apellis Pharmaceuticals shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Springbok Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $968k | 39k | 25.12 |
| 2025-06-30 | $539k | 31k | 17.31 |
| 2024-12-31 | $997k | 31k | 31.91 |
| 2024-09-30 | $835k | 29k | 28.84 |
| 2024-06-30 | $496k | 13k | 38.36 |
| 2023-06-30 | $261k | 2.9k | 91.10 |
| 2022-09-30 | $771k | 11k | 68.27 |
| 2021-06-30 | $280k | 4.4k | 63.15 |
| 2021-03-31 | $660k | 15k | 42.88 |
| 2020-06-30 | $129k | 4.0k | 32.61 |
| 2020-03-31 | $94k | 3.5k | 26.80 |
| 2019-12-31 | $6.0k | 200 | 30.00 |
| 2018-12-31 | $156k | 12k | 13.23 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management